Logo image
Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research
Journal article   Open access   Peer reviewed

Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research

Tracy A. Battaglia, Christine M. Gunn, Molly E. McCoy, Helen H. Mu, Amy S. Baranoski, Elizabeth Y. Chiao, Lisa A. Kachnic and Elizabeth A. Stier
Women's health issues, v 25(6), pp 720-726
01 Nov 2015
PMID: 26253825
url
https://europepmc.org/articles/pmc4641840View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology Social Sciences Women's Studies
Background: Infection with the human immunodeficiency virus (HIV) remains associated with a greater risk of anal cancer, despite widespread use of combination antiretroviral therapy. Evidence concerning the acceptability of anal cancer screening gives little attention to women. Because HIV-infected women have a high prevalence of depression and history of sexual trauma, understanding acceptability among this group is critical. Purpose: We sought to assess barriers and motivators to participation in anal cancer screening research among a racial/ethnically diverse HIV-infected female population. Methods: We conducted a survey based on the Health Belief Model to identify characteristics of women willing to participate in anal cancer screening research (n = 200). Bivariate analyses examined associations between willingness to participate and sociodemographics, clinical characteristics, and health beliefs. Logistic regression modeled willingness to participate in research. Main Findings: Of the women who participated, 37% screened positive for depression, 43% reported a high trauma history, and 36% screened positive for posttraumatic stress disorder. Overall, 65% reported willingness to participate in research. Those likely to participate were older, reported intravenous drug use as their HIV risk factor, and had a history of prior high-resolution anoscopy (HRA) compared with those unwilling to participate. The most commonly reported barrier to anal Pap testing was fear of pain. In adjusted analyses, a lack of fear of pain and prior experience with HRA significantly predicted willingness to participate. Conclusions: Findings suggest that, to increase participation in anal Pap and HRA-related research for HIV-infected women, a single approach may not be adequate. Rather, we must harness patients' previous experiences and address psychosocial and financial concerns to overcome barriers to participation. Copyright (C) 2015 by the Jacobs Institute of Women's Health. Published by Elsevier Inc.

Metrics

5 Record Views
16 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Public, Environmental & Occupational Health
Women's Studies
Logo image